Immunotherapy Arrives in Gastric Cancer – OncLive
OncLive |
Immunotherapy Arrives in Gastric Cancer
OncLive Whether immunotherapy can move up to an earlier setting is a great question. Those studies are being done now. Pembrolizumab was examined against a taxane in the second-line setting, and unfortunately, that was a negative study. Avelumab (Bavencio) was … |
